Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Journal of Alzheimer'S Disease Reports
|
October 28, 2025
Comparison of microglial cell population expansion in the <i>Tg344-AD</i> rat and <i>APP<sub>SWE</sub>/PS1<sub>ΔE9</sub></i> mouse model of Alzheimer's disease
Julie Hansen, Rowda Mohamed, Laura Ilkjær, et al.
ACS Chemical Neuroscience
|
September 29, 2012
Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters
Kasper Severinsen, Johan F Kraft, Heidi Koldsø, et al.
Psychosomatic Medicine
|
May 9, 2014
Association between endothelial dysfunction and depression-like symptoms in chronic mild stress model of depression
Elena V Bouzinova, Rikke Norregaard, Donna M B Boedtkjer, et al.
Journal of Alzheimer'S Disease : JAD
|
March 28, 2022
Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1ΔE9 Transgenic Mice
Mithula Sivasaravanaparan, Louise Ørum Olesen, Maurizio Severino, et al.
Frontiers in Cellular Neuroscience
|
July 6, 2018
Long-Term Stress Disrupts the Structural and Functional Integrity of GABAergic Neuronal Networks in the Medial Prefrontal Cortex of Rats
Boldizsár Czéh, Irina Vardya, Zsófia Varga, et al.
Biological Psychiatry
|
July 19, 2011
Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model
Rafael Delgado y Palacios, Adriaan Campo, Kim Henningsen, et al.
Neuron
|
September 6, 2007
Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action
Guillaume Lucas, Vladimir V Rymar, Jenny Du, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 26, 2011
Discovery of Lu AA33810: a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder
Mathivanan Packiarajan, Mohammad R Marzabadi, Mahesh Desai, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 30, 2018
Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine
Maurizio Severino, Mithula Sivasaravanaparan, Louise Ø Olesen, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Journal of Alzheimer'S Disease Reports
|
October 28, 2025
Comparison of microglial cell population expansion in the <i>Tg344-AD</i> rat and <i>APP<sub>SWE</sub>/PS1<sub>ΔE9</sub></i> mouse model of Alzheimer's disease
Julie Hansen, Rowda Mohamed, Laura Ilkjær, et al.
ACS Chemical Neuroscience
|
September 29, 2012
Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters
Kasper Severinsen, Johan F Kraft, Heidi Koldsø, et al.
Psychosomatic Medicine
|
May 9, 2014
Association between endothelial dysfunction and depression-like symptoms in chronic mild stress model of depression
Elena V Bouzinova, Rikke Norregaard, Donna M B Boedtkjer, et al.
Journal of Alzheimer'S Disease : JAD
|
March 28, 2022
Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1ΔE9 Transgenic Mice
Mithula Sivasaravanaparan, Louise Ørum Olesen, Maurizio Severino, et al.
Frontiers in Cellular Neuroscience
|
July 6, 2018
Long-Term Stress Disrupts the Structural and Functional Integrity of GABAergic Neuronal Networks in the Medial Prefrontal Cortex of Rats
Boldizsár Czéh, Irina Vardya, Zsófia Varga, et al.
Biological Psychiatry
|
July 19, 2011
Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model
Rafael Delgado y Palacios, Adriaan Campo, Kim Henningsen, et al.
Neuron
|
September 6, 2007
Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action
Guillaume Lucas, Vladimir V Rymar, Jenny Du, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 26, 2011
Discovery of Lu AA33810: a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder
Mathivanan Packiarajan, Mohammad R Marzabadi, Mahesh Desai, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 30, 2018
Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine
Maurizio Severino, Mithula Sivasaravanaparan, Louise Ø Olesen, et al.
Page
of 9